TCIM
HPTX

TIAA CREF Investment Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

TIAA CREF Investment Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-138,932
Closed -$6.38M – 3259
2015
Q1 		$6.38M Buy
138,932
+65,494
+89% +$1.96M ﹤0.01% 1455
2014
Q4 		$1.76M Buy
73,438
+16,706
+29% +$377K ﹤0.01% 2334
2014
Q3 		$1.43M Sell
56,732
-1,200
-2% -$29.8K ﹤0.01% 2434
2014
Q2 		$1.51M Buy
57,932
+21,332
+58% +$548K ﹤0.01% 2469
2014
Q1 		$944K Buy
36,600
+2,087
+6% +$56.5K ﹤0.01% 2668
2013
Q4 		$698K Hold
34,513
– – ﹤0.01% 2852
2013
Q3 		$902K Sell
34,513
-22
-0.1% -$551 ﹤0.01% 2670
2013
Q2 		$760K Buy
+34,535
New +$756K ﹤0.01% 2755

TIAA CREF Investment Management's HPTX Position: Q2 2015 in Review

TIAA CREF Investment Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 138,932 shares — an estimated $6.38M sold.

TIAA CREF Investment Management first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $6.38M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • TIAA CREF Investment Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • TIAA CREF Investment Management sold 138,932 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $6.38M.
  • TIAA CREF Investment Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • TIAA CREF Investment Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $6.38M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on TIAA CREF Investment Management's 13F filing for Q2 2015, filed 10 Aug 2015.